|Videos|June 19, 2023
mCRPC Treatment Landscape: Key Takeaways and Clinical Pearls
Author(s)Alicia K. Morgans, MD, MPH
Expert oncologist Alicia Morgans, MD, MPH, shares her hope for future improvements in metastatic castration-resistant prostate cancer management as the landscape continues to evolve.
Advertisement
Episodes in this series
Advertisement
Related to this article
VIR-5500 and [²¹²Pb]PSV359 received FDA fast track designations for prostate cancer and solitary fibrous tumors, respectively.
Advertisement
Advertisement